AlphAIAlphAI — Financial news for AI agents
247wallst.comNOV 22 min read

Tempus AI Surges 12% After Q3 Earnings Beat Adds $1.5B in Value

Tempus AI's stock rose 12% to $83.26 after its Q3 earnings exceeded expectations, adding $1.5B in market value. The company's AI-driven diagnostics business is gaining traction faster than anticipated, according to market reaction.

Original reporting
247wallst.com
Published Nov 2, 2026, 6:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 7:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Tempus AI Surges 12% After Q3 Earnings Beat Adds $1.5B in Value — source image
Source · 247wallst.com
Decision brief

The 30-second read

High
01

Why it matters

The earnings beat provides fresh data on revenue growth and profitability, influencing valuation models for AI‑health firms.

02

Market read

The surprise earnings and price jump make the story highly relevant for traders focused on AI and health‑tech equities.

03

What to watch

Potential supply constraints or regulatory scrutiny on AI‑driven diagnostics could temper upside.

Relevance 7/10Novelty 8/10Timing: today

Background

Tempus AI reported Q3 earnings that beat expectations, adding roughly $1.5 B in market value and driving a 12% intraday surge.

Market effects

Sector

AI diagnostics sector may see renewed interest after earnings beat.

Regional

U.S. tech market could get a modest lift from the surprise.

Global

Limited to investors tracking AI health‑tech companies.

Counterpoint

What could challenge this read

The rally may be short‑lived if the beat was already priced in by institutional buyers.

Key entities

  • Company
    Tempus AI

    AI‑driven diagnostics firm that reported Q3 earnings beat.

Read at source← All news

StoryTempus AI posts record Q3 revenue, first adjusted profit and raises full‑year outlook

Also covered by

6 outlets

Related articles

NOV 3
$TEMMed

Tempus AI Inc (TEM) Q3 2026 Earnings Call Highlights: Revenue Jumps 23%

Tempus AI Inc (TEM) reported Q3 2026 revenue of $411M, up 23%. CEO Lefkofsky expects sustainable 25%+ growth, with oncology and data segments driving performance. The company anticipates mid-2027 breakeven for Personalis' MRD test and predicts strong market share in MRD. Tempus also highlighted long-term data business commitments and AI-driven customer stickiness.

finance.yahoo.com2 min
NOV 2
$TEMMedAI 8/10

Tempus AI (TEM): Oncology Volume Surge and Data Licensing Bookings Signal a Profitable Inflection

Tempus AI (TEM) reported Q3 2026 revenue of $411.5M, up 23% YoY, with adjusted EBITDA of $25.6M. Oncology revenue grew 28% to $172.6M, while Data and Applications revenue increased 33% to $108.1M. The company raised full-year revenue guidance to $1.60B-$1.605B and expects near-term catalysts from reimbursement improvements and the pending $1.7B Personalis acquisition.

news.alphastreet.com7 min